Tsung-Ying Yang - JoVE Visualize

Showing results (111-120 of 174) with videos related to

Pageof 18

Sort By:

Diagnostic Microbiology and Infectious Disease|November 21, 2025

The role of P30 adhesin detected by ultrasensitive ELISA in the clinical diagnosis and management of Mycoplasma pneumoniaePo-Kai Chen, Kan-Hsuan Lin, Guan-Ming Ke, et al.

Cancers|June 24, 2022

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of <i>EGFR</i>-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable <i>EGFR</i> Mutations in Cerebrospinal FluidPei-Ya Liao, Wei-Fan Ou, Kang-Yi Su, et al.

Targeted Oncology|March 21, 2026

Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT StudyHow-Wen Ko, Ying-Ting Liao, Sheng-Kai Liang, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007

Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.

JCO Precision Oncology|May 26, 2021

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous ResponsesSheng-Fang Su, Chia-Hsin Liu, Chiou-Ling Cheng, et al.

Journal of Translational Medicine|December 2, 2024

Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum/Golgi stress and apoptosisChang-Tze Ricky Yu, Yu-Ting Amber Liao, Chi-Yin Nina Chiang, et al.

Journal of Advanced Research|July 7, 2026

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivalsPo-Hsin Lee, Pang-Ting Cheng, Ayse Celik, et al.

Journal of Thoracic Disease|February 24, 2016

Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patientsYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.

Frontiers in Oncology|March 17, 2023

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinomaPo-Hsin Lee, Chun-Ju Chiang, Jeng-Sen Tseng, et al.

Oncotargets and Therapy|June 13, 2014

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.

Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:

Pageof 18

Diagnostic Microbiology and Infectious Disease|November 21, 2025

The role of P30 adhesin detected by ultrasensitive ELISA in the clinical diagnosis and management of Mycoplasma pneumoniaePo-Kai Chen, Kan-Hsuan Lin, Guan-Ming Ke, et al.

Cancers|June 24, 2022

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of <i>EGFR</i>-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable <i>EGFR</i> Mutations in Cerebrospinal FluidPei-Ya Liao, Wei-Fan Ou, Kang-Yi Su, et al.

Targeted Oncology|March 21, 2026

Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT StudyHow-Wen Ko, Ying-Ting Liao, Sheng-Kai Liang, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007

Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.

JCO Precision Oncology|May 26, 2021

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous ResponsesSheng-Fang Su, Chia-Hsin Liu, Chiou-Ling Cheng, et al.

Journal of Translational Medicine|December 2, 2024

Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum/Golgi stress and apoptosisChang-Tze Ricky Yu, Yu-Ting Amber Liao, Chi-Yin Nina Chiang, et al.

Journal of Advanced Research|July 7, 2026

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivalsPo-Hsin Lee, Pang-Ting Cheng, Ayse Celik, et al.

Journal of Thoracic Disease|February 24, 2016

Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patientsYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.

Frontiers in Oncology|March 17, 2023

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinomaPo-Hsin Lee, Chun-Ju Chiang, Jeng-Sen Tseng, et al.

Oncotargets and Therapy|June 13, 2014

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.

Pageof 18